Q3 FY2026 · ended Sep 30, 2026 · Revenue $37.53M, +3.7% YoY · Filed Nov 5, 2026
GRAIL, Inc. (GRAL) files with the SEC under industry code 8071, Services-Medical Laboratories. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $37.5 million and a net loss of $103.6 million. Free cash flow was -$79.5 million. As of Sep 30, 2026 it held $29.0 million in cash and investments and $85.8 million in total debt.
Revenue
$37.53M
+3.7% vs year-ago quarter
Net income
$-103.57M
-16.4% vs year-ago quarter
Operating cash flow
$-74.74M
-18.2% vs year-ago quarter
Free cash flow
$-79.47M
-24.9% vs year-ago quarter
EPS
$-2.21
+10.2% vs year-ago quarter
Dividend per share
None
Shares outstanding
44.96M
+15.3% vs year-ago quarter
Net cash
$-56.87M
Q3 FY2026
Operating margin
-347.3%
TTM
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- GRAL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1699031
- Former names
- GRAIL, LLC (until Jun 12, 2024)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $37.5M | $44.7M | $40.8M | $43.6M | $36.2M |
| Operating income | -$144.6M | -$173.8M | -$135.8M | -$124.4M | -$125.3M |
| Net income | -$103.6M | -$110.2M | -$93.2M | -$99.2M | -$89.0M |
| Diluted EPS | -$2.21 | -$2.56 | -$2.29 | -$2.44 | -$2.46 |
| Operating cash flow | -$74.7M | -$80.7M | -$87.0M | -$63.8M | -$63.2M |
| Free cash flow | -$79.5M | -$81.2M | -$87.5M | -$63.9M | -$63.6M |
| Total assets | $2.7B | $2.8B | $2.8B | $2.9B | $2.6B |
| Total liabilities | $277.0M | $301.0M | $302.8M | $344.2M | $361.1M |
| Stockholders' equity | $2.5B | $2.5B | $2.5B | $2.6B | $2.2B |
| Cash and investments | $29.0M | $55.6M | $69.3M | $249.7M | $126.9M |
| Total debt | $85.8M | $91.3M | $51.0M | $54.9M | $58.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
All 265 GRAIL, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.